Nectar to Sell API, Formulations and Menthol Units to Ceph for INR 1,290 Cr
Nectar Lifesciences Ltd. is selling its core business division for INR 1,270 crore and its menthol business for INR 20 crore to Ceph Lifesciences.
Menthol | 09/07/2025 | By Dineshwori | 197
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy